Clinical Research Directory
Browse clinical research sites, groups, and studies.
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
Sponsor: OHSU Knight Cancer Institute
Summary
This clinical trial tests the effectiveness of an online weight loss plus resistance training intervention (iLIVE) to decrease obesity and improve frailty in men with prostate cancer who received androgen deprivation therapy (ADT). Androgen deprivation therapy increases the risk of frailty, weight gain and obesity in prostate cancer survivors. The combination of frailty and obesity can lead to a decrease in quality of life and an increased risk of recurrent falls. Using iLIVE may improve obesity and frailty in men with prostate cancer who receive ADT.
Official title: Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors (iLIVE)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
250
Start Date
2024-03-12
Completion Date
2027-12-31
Last Updated
2025-05-31
Healthy Volunteers
No
Conditions
Interventions
Internet-Based Exercise Intervention
Participate in online supervised, group resistance training sessions (iLIVE)
Internet-Based Diet Intervention
Receive online access to an interactive website with a series of weekly self-directed and interactive sessions on various topics associated with diet and weight loss (iLIVE)
Education Intervention
Receive usual care receiving educational information about diet and exercise for cancer survivors
Locations (2)
University of Alabama
Birmingham, Alabama, United States
OHSU Knight Cancer Institute
Portland, Oregon, United States